BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33091625)

  • 1. Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation.
    Carvalho AM; Soares da Costa D; Paulo PMR; Reis RL; Pashkuleva I
    Acta Biomater; 2021 Jan; 119():114-124. PubMed ID: 33091625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
    Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
    Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells.
    Pilarski LM; Pruski E; Wizniak J; Paine D; Seeberger K; Mant MJ; Brown CB; Belch AR
    Blood; 1999 May; 93(9):2918-27. PubMed ID: 10216086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
    Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
    Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
    Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
    J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronate receptors mediating glioma cell migration and proliferation.
    Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
    J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
    Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
    Leng Y; Abdullah A; Wendt MK; Calve S
    Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.
    Kouvidi K; Berdiaki A; Nikitovic D; Katonis P; Afratis N; Hascall VC; Karamanos NK; Tzanakakis GN
    J Biol Chem; 2011 Nov; 286(44):38509-38520. PubMed ID: 21914806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic Acid (HA) Receptors and the Motility of Schwann Cell(-Like) Phenotypes.
    Ouasti S; Faroni A; Kingham PJ; Ghibaudi M; Reid AJ; Tirelli N
    Cells; 2020 Jun; 9(6):. PubMed ID: 32560323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
    Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
    Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis.
    Savani RC; Cao G; Pooler PM; Zaman A; Zhou Z; DeLisser HM
    J Biol Chem; 2001 Sep; 276(39):36770-8. PubMed ID: 11448954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.
    Park D; Kim Y; Kim H; Kim K; Lee YS; Choe J; Hahn JH; Lee H; Jeon J; Choi C; Kim YM; Jeoung D
    Mol Cells; 2012 Jun; 33(6):563-74. PubMed ID: 22610405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion.
    Turley EA; Austen L; Moore D; Hoare K
    Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.
    Shigeishi H; Higashikawa K; Takechi M
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1629-40. PubMed ID: 24676428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.
    Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
    Lab Invest; 2011 Mar; 91(3):379-91. PubMed ID: 20956971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
    Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
    Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation.
    Gouëffic Y; Guilluy C; Guérin P; Patra P; Pacaud P; Loirand G
    Cardiovasc Res; 2006 Nov; 72(2):339-48. PubMed ID: 16934786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.